CXXIF
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Sep 5 closing price
Capitalization
39.27M
GTBIF
Price
$8.27
Change
+$0.36 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.92B
Interact to see
Advertisement

CXXIF vs GTBIF

Header iconCXXIF vs GTBIF Comparison
Open Charts CXXIF vs GTBIFBanner chart's image
C21 Investments
Price$0.34
Change+$0.02 (+6.25%)
Volume$41.22K
Capitalization39.27M
Green Thumb Industries
Price$8.27
Change+$0.36 (+4.55%)
Volume$211.33K
Capitalization1.92B
CXXIF vs GTBIF Comparison Chart in %
Loading...
CXXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CXXIF vs. GTBIF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CXXIF is a Hold and GTBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CXXIF: $0.34 vs. GTBIF: $8.27)
Brand notoriety: CXXIF and GTBIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CXXIF: 26% vs. GTBIF: 29%
Market capitalization -- CXXIF: $39.27M vs. GTBIF: $1.92B
CXXIF [@Pharmaceuticals: Generic] is valued at $39.27M. GTBIF’s [@Pharmaceuticals: Generic] market capitalization is $1.92B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CXXIF’s FA Score shows that 1 FA rating(s) are green whileGTBIF’s FA Score has 1 green FA rating(s).

  • CXXIF’s FA Score: 1 green, 4 red.
  • GTBIF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CXXIF and GTBIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CXXIF’s TA Score shows that 4 TA indicator(s) are bullish while GTBIF’s TA Score has 4 bullish TA indicator(s).

  • CXXIF’s TA Score: 4 bullish, 5 bearish.
  • GTBIF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CXXIF and GTBIF are a bad buy in the short-term.

Price Growth

CXXIF (@Pharmaceuticals: Generic) experienced а -20.33% price change this week, while GTBIF (@Pharmaceuticals: Generic) price change was -4.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.09%. For the same industry, the average monthly price growth was +9.01%, and the average quarterly price growth was +87.13%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.09% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GTBIF($1.92B) has a higher market cap than CXXIF($39.3M). CXXIF YTD gains are higher at: 70.500 vs. GTBIF (1.224). GTBIF has higher annual earnings (EBITDA): 338M vs. CXXIF (4.72M). GTBIF has more cash in the bank: 177M vs. CXXIF (2.66M). CXXIF has less debt than GTBIF: CXXIF (12.9M) vs GTBIF (523M). GTBIF has higher revenues than CXXIF: GTBIF (1.15B) vs CXXIF (32.1M).
CXXIFGTBIFCXXIF / GTBIF
Capitalization39.3M1.92B2%
EBITDA4.72M338M1%
Gain YTD70.5001.2245,760%
P/E RatioN/A75.18-
Revenue32.1M1.15B3%
Total Cash2.66M177M2%
Total Debt12.9M523M2%
FUNDAMENTALS RATINGS
CXXIF vs GTBIF: Fundamental Ratings
CXXIF
GTBIF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9591
PRICE GROWTH RATING
1..100
3640
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GTBIF's Valuation (85) in the null industry is in the same range as CXXIF (98). This means that GTBIF’s stock grew similarly to CXXIF’s over the last 12 months.

GTBIF's Profit vs Risk Rating (100) in the null industry is in the same range as CXXIF (100). This means that GTBIF’s stock grew similarly to CXXIF’s over the last 12 months.

GTBIF's SMR Rating (91) in the null industry is in the same range as CXXIF (95). This means that GTBIF’s stock grew similarly to CXXIF’s over the last 12 months.

CXXIF's Price Growth Rating (36) in the null industry is in the same range as GTBIF (40). This means that CXXIF’s stock grew similarly to GTBIF’s over the last 12 months.

CXXIF's P/E Growth Rating (7) in the null industry is in the same range as GTBIF (9). This means that CXXIF’s stock grew similarly to GTBIF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CXXIFGTBIF
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CXXIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIAF22.061.25
+5.99%
Epiroc Aktiebolag
APXIF11.84N/A
N/A
APx Acquisition Corp. I
EVTZF8.82N/A
N/A
Evertz Technologies Ltd.
JPSWY30.53N/A
N/A
The Japan Steel Works, Ltd.
LNCLF0.12N/A
N/A
Lincoln Gold Mng Inc.

CXXIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CXXIF has been loosely correlated with CRLBF. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CXXIF jumps, then CRLBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CXXIF
1D Price
Change %
CXXIF100%
+6.76%
CRLBF - CXXIF
53%
Loosely correlated
+5.26%
CURLF - CXXIF
52%
Loosely correlated
+1.79%
GTBIF - CXXIF
52%
Loosely correlated
+4.55%
TCNNF - CXXIF
51%
Loosely correlated
+4.55%
TSNDF - CXXIF
51%
Loosely correlated
+13.08%
More

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with CURLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then CURLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+4.55%
CURLF - GTBIF
82%
Closely correlated
+1.79%
TCNNF - GTBIF
82%
Closely correlated
+4.55%
VRNOF - GTBIF
79%
Closely correlated
+5.51%
TSNDF - GTBIF
77%
Closely correlated
+13.08%
CRLBF - GTBIF
71%
Closely correlated
+5.26%
More